Aminoacyl-tRNA Synthetases, Indispensable Players in Lung Tumorigenesis

Pratyasha Bhowal1, Priyanka Biswas Karmakar1, Debkanya Dey1

  • 1Department of Biotechnology, Dr. B.C. Guha Centre for Genetic Engineering and Biotechnology, Faculty of Science, University of Calcutta, Kolkata, India.

Insights

Aminoacyl-tRNA synthetases (aaRSs) and AIMPs form complexes involved in lung cancer. This review explores their roles in tumorigenesis and potential as novel therapeutics for lung cancer treatment.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • Aminoacyl-tRNA synthetases (aaRSs) are essential enzymes for protein synthesis with conserved functions.
  • Emerging research reveals non-canonical roles for aaRSs and associated proteins (AIMPs) beyond protein synthesis.
  • These proteins form a multi-tRNA synthetase complex (MSC), implicating them in various cellular processes.

Purpose of the Study:

  • To review the structure and function of the multi-tRNA synthetase complex (MSC).
  • To elucidate the involvement of aaRSs and AIMPs in the maintenance and progression of lung cancer.
  • To discuss the molecular mechanisms underlying their roles in lung tumorigenesis.

Main Methods:

  • Literature review focusing on studies investigating aaRSs, AIMPs, and lung cancer.
  • Analysis of the structural organization of the MSC.
  • Examination of molecular pathways implicated in lung tumorigenesis involving these protein complexes.

Main Results:

  • aaRSs and AIMPs play crucial roles in regulating lung cancer.
  • Evidence suggests their involvement in both the initiation and progression of lung tumorigenesis.
  • Specific molecular mechanisms of action within lung cancer cells are being uncovered.

Conclusions:

  • The aaRS-AIMPs complex has significant implications in lung cancer regulation.
  • These proteins represent promising therapeutic targets for novel lung cancer treatments.
  • Further research into the MSC could lead to advanced therapeutic strategies for lung tumorigenesis.

Related Concept Videos

tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
20.4K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
12.3K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
16.2K
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
284
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
12.0K